Transforming Paediatric Care: Virtual Care Modalities Prove Effective and Promising in Quebec

By Staff Writer

August 24, 2023

In the face of an ageing population, increased chronic diseases, and limited professional resources, Quebec is turning to virtual care tools to meet the growing demand for home and institutional care. This shift has been further accelerated by the COVID-19 pandemic, which has highlighted the potential of virtual care in specialty medicine. The Quebec Ministry of Health and Social Services (MSSS) has tasked the National Institute for Excellence in Health and Social Services (INESSS) with providing a state-of-knowledge report to guide the use of virtual care in specialty medicine.

The report, which covers seven areas including paediatrics, psychiatry, neurology, haematology/oncology, respirology, general surgery, and internal medicine, is aimed at informing public decision-makers, medical associations, and health and social services professionals about virtual care practices. The findings, based on a scoping review of scientific and grey literature from the past five years, reveal promising results for the use of virtual care modalities in paediatrics.

Virtual care interventions such as teleconsultation, telemonitoring, tele education, teleassistance, and tele intervention have shown effectiveness in assessing, diagnosing, monitoring, and treating a range of paediatric conditions. These include neurodevelopmental disorders, certain cancers, dermatological conditions, and acute conditions requiring emergency or intensive care.

The report also highlights potential benefits of virtual care in improving access to health care for children with chronic illnesses, those in underprivileged areas, and those in remote or rural areas. Patient and care provider satisfaction with virtual care modalities is reported as high, with virtual care deemed as safe and secure as in-person care.

While the report acknowledges limitations, including the need for further quality studies, it underscores the transformative potential of virtual care in paediatrics. As Quebec continues to navigate the challenges of healthcare delivery, virtual care modalities offer a promising pathway to improved patient care and engagement.

Reference url

Recent Posts

pharmaceutical pricing issues
      

Pharmaceutical Pricing Issues: Beyond Overpricing and Profit Motives

💊 Are high drug prices justified by R&D investments, or is there more to the story?

In a thought-provoking critique, a recent BMJ article argues that profit motives are driving pharmaceutical pricing issues while highlighting the tough decisions regarding access to Alzheimer’s drugs in the UK. It raises vital concerns about the implications for lower-income countries and emphasizes the need for a balanced discussion on drug pricing and innovation.

Curious about the complexities of pharmaceutical pricing and how they shape global health access? Dive into the full article for a nuanced exploration!

#SyenzaNews #pharmaceuticals #HealthEconomics #healthcarepolicy

Zimislecel type 1 diabetes
   

Cell Therapy for Type 1 Diabetes: Vertex Trial Results and Market Potential

🚀 What if we could revolutionize Type 1 diabetes treatment?

Vertex Pharmaceuticals has made significant strides with its promising phase 1/2 trial results for **zimislecel**, a stem cell-derived therapy that not only restores insulin production but also drastically reduces severe hypoglycemic events. As phase 3 trials commence, this breakthrough could reshape care for T1D patients and potentially reduce long-term healthcare costs.

Curious to learn how zimislecel and other potential cell therapies may redefine diabetes management? Click to read more!

#SyenzaNews #biotechnology #HealthEconomics

biosimilar clinical approach
    

Biosimilar Clinical Approach

🚀 How is the EMA’s new biosimilar clinical approach changing the landscape of drug approvals in Europe?

With a focus on tailored clinical assessments, the EMA is streamlining the pathway for biosimilars by allowing analytical data to take precedence over large-scale comparative efficacy studies. This shift promises to enhance patient access to life-saving therapies while maintaining rigorous safety standards.

Dive deeper into the implications of this innovative regulatory approach and find out how it can impact health economics and market access.

👉 Read more in the full article!
#SyenzaNews #regulatoryaffairs #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.